Salkind Gene (CIK 1592481) reported 10 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-02-13). Recent activity: Buy COEP (5,700 shares), Buy COEP (3,250 shares), Buy UPXI (50,000 shares), Buy UPXI (100,000 shares), Buy UPXI (100,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-13 | Coeptis Therapeutics Holdings, Inc. (COEP) | Director | Buy | 5,700 | $60,192 |
| 2026-02-13 | Coeptis Therapeutics Holdings, Inc. (COEP) | Director | Buy | 3,250 | $0 |
| 2025-11-21 | UPEXI, INC. (UPXI) | Director | Buy | 50,000 | $127,500 |
| 2025-11-18 | UPEXI, INC. (UPXI) | Director | Buy | 100,000 | $265,000 |
| 2025-11-18 | UPEXI, INC. (UPXI) | Director | Buy | 100,000 | $281,000 |
| 2025-09-19 | Mobiquity Technologies, Inc. (MOBQ) | Director | Buy | 25,000 | $25,000 |
| 2025-07-30 | UPEXI, INC. (UPXI) | Director | Buy | 20,243 | $100,000 |
| 2025-07-30 | UPEXI, INC. (UPXI) | Director | Buy | 50,000 | $0 |
| 2025-07-30 | UPEXI, INC. (UPXI) | Director | Buy | 150,000 | $0 |
| 2025-04-25 | UPEXI, INC. (UPXI) | Director | Buy | 241,229 | $550,002 |
Source: SEC Form 4 filings · as of 2026-02-13